CatsWannaBeCats.Com | Thorpe Harper | Activity https://www.catswannabecats.com/members/heavensubway10/activity/ Activity feed for Thorpe Harper. Tue, 16 Jun 2026 15:30:45 -0400 https://buddypress.org/?v=7.2.0 en-CA 30 hourly 2 dd307609a1f578766035850b26b70f3a Thorpe Harper posted an update: he advantages of RPLS by avoiding the need for abdominal […] https://www.catswannabecats.com/activity/p/26375/ Tue, 10 Jun 2025 10:29:56 -0400 he advantages of RPLS by avoiding the need for abdominal wall specimen extraction in patients with tumor diameter ≤ 5 cm. Surgical and oncologic safety are comparable to RPLS with CSE.During their intrathymic development, nascent T cells are empowered to protect against pathogens and to be operative for a life-long acceptance of self. While autor…[Read more]

]]> 0 1700d4fd6be84e1bd8b285bdeb4bf72c Thorpe Harper posted an update: 35, p=0.004) and between MCBS and price (|ρ|=0.33, […] https://www.catswannabecats.com/activity/p/12574/ Sun, 01 Jun 2025 11:11:42 -0400 35, p=0.004) and between MCBS and price (|ρ|=0.33, p=0.005). Correlations between added benefit and prices were similar or higher for first indications (ASMR, |ρ|=0.37, p=0.030; MCBS, |ρ|=0.48, p=0.004). In first indications, mean monthly prices increased €3954 for drugs without ASMR added benefit. The mean annual price and price increase for firs…[Read more]

]]> 0 a53267c11fcbe97256de6c1f5db62377 Thorpe Harper posted an update: Sensitivity analyses were used to determine the robustness […] https://www.catswannabecats.com/activity/p/11949/ Sun, 01 Jun 2025 08:28:45 -0400 Sensitivity analyses were used to determine the robustness of the results.

In our theoretical cohort of 4000 women, treatment with the addition of trastuzumab resulted in 637 fewer deaths and 627 fewer cases of progression compared with treatment with carboplatin/paclitaxel alone. Treatment with trastuzumab was associated with an…[Read more]

]]> 0 324237ac3daf53ed3a98422399d6c508 Thorpe Harper became a registered member https://www.catswannabecats.com/activity/p/10689/ Sun, 01 Jun 2025 02:26:07 -0400 0